HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wenxin Yu Selected Research

Port-Wine Stain (Nevus Flammeus)

3/2022Histological Characteristics of Port-Wine Stains with Complete Regression After Photodynamic Therapy Treatment: A 7-Year Follow-Up.
1/2022Can 595-nm Pulsed Dye Laser in Conjunction With an Optical Clearing Agent Improve the Treatment of Port-Wine Stains?
12/2021Recurrence of Port-Wine Stain After Photodynamic Therapy: A Case Report with a 22-Year Follow-Up.
9/2021Imaging and Pathological Characteristics of Port-Wine Stain Patients with Tissue Hypertrophy Before Laser Therapy: Retrospective Data.
7/2021Blood Perfusion May Determine the Therapeutic Effect of Pulsed Dye Laser on Port-Wine Stains Located on Extremities.
1/2021Combination Therapy of Pulsed Dye Laser With Intense Pulsed Light in Port-Wine Stain Treatment: A Prospective Side-by-Side Comparison.
4/2020Retrospective study of photodynamic therapy for pulsed dye laser-resistant port-wine stains.
1/2020Assessment of Outcomes With Pulsed Dye Laser Treatment of Port-Wine Stains Located Proximally vs Distally on Extremities.
6/2019Comparison of Two Generation Photosensitizers of PsD-007 and Hematoporphyrin Monomethyl Ether Photodynamic Therapy for Treatment of Port-Wine Stain: A Retrospective Study.
3/2019Port-wine stains on the neck respond better to a pulsed dye laser than lesions on the face: An intrapatient comparison study with histopathology.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wenxin Yu Research Topics

Disease

17Port-Wine Stain (Nevus Flammeus)
03/2022 - 03/2015
4Hemangioma (Angioma)
06/2017 - 02/2014
3Alzheimer Disease (Alzheimer's Disease)
08/2007 - 03/2004
2Pain (Aches)
04/2018 - 03/2017
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
12/2002 - 05/2002
1Hyperpigmentation
12/2021
1Melanoma (Melanoma, Malignant)
12/2021
1Hypertrophy
09/2021
1Nevus of Ota
09/2018
1Capillary Malformation-Arteriovenous Malformation
01/2018
1Contusions
03/2017
1Hemorrhage
03/2017
1Hematoma
03/2017
1Ecchymosis
01/2017
1Lymphangioma (Cavernous Lymphangioma)
08/2014
1Mitochondrial Diseases (Mitochondrial Disease)
03/2005
1Coronary Disease (Coronary Heart Disease)
12/2002
1Coronary Artery Disease (Coronary Atherosclerosis)
05/2002
1Tangier Disease
01/2002

Drug/Important Bio-Agent (IBA)

4CholesterolIBA
04/2005 - 12/2002
31-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2022 - 03/2015
3Propranolol (Inderal)FDA LinkGeneric
05/2016 - 02/2014
2hematoporphyrin monomethyl etherIBA
04/2020 - 06/2019
2Anesthetics (Anesthetic Agents)IBA
04/2018 - 03/2017
2Proteins (Proteins, Gene)FDA Link
01/2018 - 04/2005
2Amyloid beta-PeptidesIBA
08/2007 - 04/2005
1Melanins (Melanin)IBA
12/2021
1NanogelsIBA
12/2021
1Tranexamic Acid (AMCA)FDA Link
12/2021
1Monophenol Monooxygenase (Tyrosinase)IBA
12/2021
1Hyaluronic Acid (Hyaluronan)IBA
12/2021
1Liposomes (Liposome)IBA
12/2021
1Therapeutic UsesIBA
07/2021
1photocarcinorinIBA
06/2019
1Photosensitizing Agents (Photosensitizers)IBA
06/2019
1alexandriteIBA
09/2018
1Prilocaine Drug Combination LidocaineFDA LinkGeneric
04/2018
1Timolol (Blocadren)FDA LinkGeneric
06/2017
1Amyloid (Amyloid Fibrils)IBA
04/2005
1LipidsIBA
04/2005
1GlycosphingolipidsIBA
04/2005
1Adenosine Triphosphate (ATP)IBA
03/2005
1SphingolipidsIBA
03/2004
1oxidized low density lipoproteinIBA
12/2002
1DNA (Deoxyribonucleic Acid)IBA
12/2002
1LDL Receptors (LDL Receptor)IBA
12/2002
1LDL CholesterolIBA
12/2002
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2002
1Estrogen ReceptorsIBA
05/2002
1Estrogen Receptor alphaIBA
05/2002
1NucleotidesIBA
01/2002
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2002
1HDL LipoproteinsIBA
01/2002

Therapy/Procedure

13Dye Lasers
01/2022 - 03/2016
5Photochemotherapy (Photodynamic Therapy)
03/2022 - 03/2015
3Lasers (Laser)
12/2021 - 04/2018
2Laser Therapy (Surgery, Laser)
09/2021 - 03/2015
2Therapeutics
01/2021 - 08/2014
2Anesthesia
04/2018 - 03/2017
2Blepharoplasty
03/2017 - 01/2017
1Solid-State Lasers
09/2018
1Local Anesthesia
03/2017
1Injections
03/2017
1Electrocoagulation (Electrocautery)
08/2014